Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 37371096)

  • 1. Ferroptosis-Mediated Cell Death Induced by NCX4040, The Non-Steroidal Nitric Oxide Donor, in Human Colorectal Cancer Cells: Implications in Therapy.
    Sinha BK; Bortner CD; Jarmusch AK; Tokar EJ; Murphy C; Wu X; Winter H; Cannon RE
    Cells; 2023 Jun; 12(12):. PubMed ID: 37371096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid Peroxidation-Dependent Cell Death Regulated by GPx4 and Ferroptosis.
    Imai H; Matsuoka M; Kumagai T; Sakamoto T; Koumura T
    Curr Top Microbiol Immunol; 2017; 403():143-170. PubMed ID: 28204974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Mechanisms of Cytotoxicity of NCX4040, the Non-Steroidal Anti-Inflammatory NO-Donor, in Human Ovarian Cancer Cells.
    Sinha BK; Tokar EJ; Bortner CD
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene Expression Profiling Elucidates Cellular Responses to NCX4040 in Human Ovarian Tumor Cells: Implications in the Mechanisms of Action of NCX4040.
    Sinha BK; Tokar EJ; Li J; Bushel PR
    Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RSL3 Drives Ferroptosis Through GPX4 Inactivation and ROS Production in Colorectal Cancer.
    Sui X; Zhang R; Liu S; Duan T; Zhai L; Zhang M; Han X; Xiang Y; Huang X; Lin H; Xie T
    Front Pharmacol; 2018; 9():1371. PubMed ID: 30524291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RSL3 and Erastin differentially regulate redox signaling to promote Smac mimetic-induced cell death.
    Dächert J; Schoeneberger H; Rohde K; Fulda S
    Oncotarget; 2016 Sep; 7(39):63779-63792. PubMed ID: 27588473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell growth potential drives ferroptosis susceptibility in rhabdomyosarcoma and myoblast cell lines.
    Codenotti S; Poli M; Asperti M; Zizioli D; Marampon F; Fanzani A
    J Cancer Res Clin Oncol; 2018 Sep; 144(9):1717-1730. PubMed ID: 29971532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resibufogenin inhibited colorectal cancer cell growth and tumorigenesis through triggering ferroptosis and ROS production mediated by GPX4 inactivation.
    Shen LD; Qi WH; Bai JJ; Zuo CY; Bai DL; Gao WD; Zong XL; Hao TT; Ma Y; Cao GC
    Anat Rec (Hoboken); 2021 Feb; 304(2):313-322. PubMed ID: 31961485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [MACC1 knockdown enhances RSL3-induced ferroptosis in human colorectal cancer cells by inhibiting GPX4 expression].
    Sun S; Huang X; Li G; Zhang C; Lu Z; Zhang W; Li Z; Yang Q
    Nan Fang Yi Ke Da Xue Xue Bao; 2024 Jan; 44(1):173-178. PubMed ID: 38293989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of SRSF9 enhances the sensitivity of colorectal cancer to erastin-induced ferroptosis by reducing glutathione peroxidase 4 expression.
    Wang R; Su Q; Yin H; Wu D; Lv C; Yan Z
    Int J Biochem Cell Biol; 2021 May; 134():105948. PubMed ID: 33609745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-545 promotes colorectal cancer by inhibiting transferring in the non-normal ferroptosis signaling.
    Zheng S; Hu L; Song Q; Shan Y; Yin G; Zhu H; Kong W; Zhou C
    Aging (Albany NY); 2021 Dec; 13(24):26137-26147. PubMed ID: 34954694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cetuximab promotes RSL3-induced ferroptosis by suppressing the Nrf2/HO-1 signalling pathway in KRAS mutant colorectal cancer.
    Yang J; Mo J; Dai J; Ye C; Cen W; Zheng X; Jiang L; Ye L
    Cell Death Dis; 2021 Nov; 12(11):1079. PubMed ID: 34775496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoxygenase inhibitors protect acute lymphoblastic leukemia cells from ferroptotic cell death.
    Probst L; Dächert J; Schenk B; Fulda S
    Biochem Pharmacol; 2017 Sep; 140():41-52. PubMed ID: 28595877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of ferroptosis by photodynamic therapy and enhancement of antitumor effect with ferroptosis inducers.
    Kojima Y; Tanaka M; Sasaki M; Ozeki K; Shimura T; Kubota E; Kataoka H
    J Gastroenterol; 2024 Feb; 59(2):81-94. PubMed ID: 37947872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GPX4 overexpressed non-small cell lung cancer cells are sensitive to RSL3-induced ferroptosis.
    Kim JW; Min DW; Kim D; Kim J; Kim MJ; Lim H; Lee JY
    Sci Rep; 2023 May; 13(1):8872. PubMed ID: 37258589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combinative treatment of β-elemene and cetuximab is sensitive to KRAS mutant colorectal cancer cells by inducing ferroptosis and inhibiting epithelial-mesenchymal transformation.
    Chen P; Li X; Zhang R; Liu S; Xiang Y; Zhang M; Chen X; Pan T; Yan L; Feng J; Duan T; Wang D; Chen B; Jin T; Wang W; Chen L; Huang X; Zhang W; Sun Y; Li G; Kong L; Chen X; Li Y; Yang Z; Zhang Q; Zhuo L; Sui X; Xie T
    Theranostics; 2020; 10(11):5107-5119. PubMed ID: 32308771
    [No Abstract]   [Full Text] [Related]  

  • 17. Nrf2 inhibition reverses resistance to GPX4 inhibitor-induced ferroptosis in head and neck cancer.
    Shin D; Kim EH; Lee J; Roh JL
    Free Radic Biol Med; 2018 Dec; 129():454-462. PubMed ID: 30339884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ferroptosis in colorectal cancer: Potential mechanisms and effective therapeutic targets.
    Wang Y; Zhang Z; Sun W; Zhang J; Xu Q; Zhou X; Mao L
    Biomed Pharmacother; 2022 Sep; 153():113524. PubMed ID: 36076606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoxygenase-mediated generation of lipid peroxides enhances ferroptosis induced by erastin and RSL3.
    Shintoku R; Takigawa Y; Yamada K; Kubota C; Yoshimoto Y; Takeuchi T; Koshiishi I; Torii S
    Cancer Sci; 2017 Nov; 108(11):2187-2194. PubMed ID: 28837253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effects of the mechanistic target of rapamycin against excess iron and ferroptosis in cardiomyocytes.
    Baba Y; Higa JK; Shimada BK; Horiuchi KM; Suhara T; Kobayashi M; Woo JD; Aoyagi H; Marh KS; Kitaoka H; Matsui T
    Am J Physiol Heart Circ Physiol; 2018 Mar; 314(3):H659-H668. PubMed ID: 29127238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.